236 related articles for article (PubMed ID: 26928949)
1. Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice.
Yao L; Wang C; Zhang X; Peng L; Liu W; Zhang X; Liu Y; He J; Jiang C; Ai D; Zhu Y
Hepatology; 2016 Jul; 64(1):92-105. PubMed ID: 26928949
[TBL] [Abstract][Full Text] [Related]
2. [n-3 Polyunsaturated fatty acid attenuates hyperhomocysteinemia-induced hepatic steatosis by increasing hepatic LXA
Song H; Duan JJ; Li K; Yao L; Zhu Y
Sheng Li Xue Bao; 2021 Aug; 73(4):551-558. PubMed ID: 34405211
[TBL] [Abstract][Full Text] [Related]
3. A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis.
Lee JH; Wada T; Febbraio M; He J; Matsubara T; Lee MJ; Gonzalez FJ; Xie W
Gastroenterology; 2010 Aug; 139(2):653-63. PubMed ID: 20303349
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of soluble epoxide hydrolase ameliorates hyperhomocysteinemia-induced hepatic steatosis by enhancing β-oxidation of fatty acid in mice.
Yao L; Cao B; Cheng Q; Cai W; Ye C; Liang J; Liu W; Tan L; Yan M; Li B; He J; Hwang SH; Zhang X; Wang C; Ai D; Hammock BD; Zhu Y
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G527-G538. PubMed ID: 30789748
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine Induces Hepatic Steatosis Involving ER Stress Response in High Methionine Diet-Fed Mice.
Ai Y; Sun Z; Peng C; Liu L; Xiao X; Li J
Nutrients; 2017 Apr; 9(4):. PubMed ID: 28368295
[TBL] [Abstract][Full Text] [Related]
6. Activation of the aryl hydrocarbon receptor induces hepatic steatosis via the upregulation of fatty acid transport.
Kawano Y; Nishiumi S; Tanaka S; Nobutani K; Miki A; Yano Y; Seo Y; Kutsumi H; Ashida H; Azuma T; Yoshida M
Arch Biochem Biophys; 2010 Dec; 504(2):221-7. PubMed ID: 20831858
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1.
Xiang W; Yang Y; Weng L; Ye Z; Ding P; Li H; Sun J; Zeng C
Int Immunopharmacol; 2023 May; 118():110085. PubMed ID: 37018978
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 PUFA ameliorates hyperhomocysteinemia-induced hepatic steatosis in mice by inhibiting hepatic ceramide synthesis.
Dong YQ; Zhang XZ; Sun LL; Zhang SY; Liu B; Liu HY; Wang X; Jiang CT
Acta Pharmacol Sin; 2017 Dec; 38(12):1601-1610. PubMed ID: 28933423
[TBL] [Abstract][Full Text] [Related]
9. Orphan nuclear receptor NR4A1 suppresses hyperhomocysteinemia-induced hepatic steatosis in vitro and in vivo.
Liang H; Xie X; Song X; Huang M; Su T; Chang X; Liang B; Huang D
FEBS Lett; 2019 May; 593(10):1061-1071. PubMed ID: 30973961
[TBL] [Abstract][Full Text] [Related]
10. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
[TBL] [Abstract][Full Text] [Related]
11. PEGylated Curcumin Derivative Attenuates Hepatic Steatosis via CREB/PPAR-
Liu Y; Cheng F; Luo Y; Zhan Z; Hu P; Ren H; Tang H; Peng M
Biomed Res Int; 2017; 2017():8234507. PubMed ID: 28770225
[TBL] [Abstract][Full Text] [Related]
12. [Alleviating effects of hydrogen on hyperhomocysteinemia and fatty liver induced by high-methionine diet].
Chu WB; Ding TQ; Wen B; Lu JY; Fan R; Chen XW
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Nov; 38(6):787-792. PubMed ID: 37308436
[No Abstract] [Full Text] [Related]
13. Aryl Hydrocarbon Receptor Plays Protective Roles against High Fat Diet (HFD)-induced Hepatic Steatosis and the Subsequent Lipotoxicity via Direct Transcriptional Regulation of Socs3 Gene Expression.
Wada T; Sunaga H; Miyata K; Shirasaki H; Uchiyama Y; Shimba S
J Biol Chem; 2016 Mar; 291(13):7004-16. PubMed ID: 26865635
[TBL] [Abstract][Full Text] [Related]
14. Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice.
Geng T; Xia L; Russo S; Kamara D; Cowart LA
Nutr Res; 2015 Sep; 35(9):812-22. PubMed ID: 26277244
[TBL] [Abstract][Full Text] [Related]
15. Regulation of hepatic lipid deposition by phospholipid in large yellow croaker.
Cai Z; Mai K; Ai Q
Br J Nutr; 2017 Dec; 118(12):999-1009. PubMed ID: 29198193
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo approaches for identifying the role of aryl hydrocarbon receptor in the development of nonalcoholic fatty liver disease.
Zhu XY; Xia HG; Wang ZH; Li B; Jiang HY; Li DL; Jin R; Jin Y
Toxicol Lett; 2020 Feb; 319():85-94. PubMed ID: 31730885
[TBL] [Abstract][Full Text] [Related]
17. Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice.
Choi YJ; Lee KY; Jung SH; Kim HS; Shim G; Kim MG; Oh YK; Oh SH; Jun DW; Lee BH
Toxicol Appl Pharmacol; 2017 Feb; 316():74-82. PubMed ID: 28038998
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors.
Woo CW; Siow YL; Pierce GN; Choy PC; Minuk GY; Mymin D; O K
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1002-10. PubMed ID: 15644462
[TBL] [Abstract][Full Text] [Related]
19. Arylhydrocarbon receptor-dependent mIndy (Slc13a5) induction as possible contributor to benzo[a]pyrene-induced lipid accumulation in hepatocytes.
Neuschäfer-Rube F; Schraplau A; Schewe B; Lieske S; Krützfeldt JM; Ringel S; Henkel J; Birkenfeld AL; Püschel GP
Toxicology; 2015 Nov; 337():1-9. PubMed ID: 26303333
[TBL] [Abstract][Full Text] [Related]
20. Involvement of CYP2E1-ROS-CD36/DGAT2 axis in the pathogenesis of VPA-induced hepatic steatosis in vivo and in vitro.
Ma L; Wang Y; Chen X; Zhao L; Guo Y
Toxicology; 2020 Dec; 445():152585. PubMed ID: 33007364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
